To test whether inhibition of PAFR enhance the sensitivity of PCa to ionizing irradiation, we chose a castration-resistant and highly metastatic (PC3) and a androgen-dependent and lowly metastatic prostate adenocarcinoma cell lines. The gene discussed is PTAFR; the disease is prostate adenocarcinoma.